The application of nanotechnology in medicine has the potential to make a great impact on
human health, ranging from prevention to diagnosis and treatment of disease. The kidneys …

Abstract Treatment and management of kidney disease currently presents an enormous
global burden, and the application of nanotechnology principles to renal disease therapy …

Renal cell carcinoma (RCC) is a common urinary tract tumor that arises from the highly
heterogeneous epithelium of the renal tubules. The incidence of kidney cancer is second …

Renal cell carcinoma (RCC) is a common urological malignancy and represents a leading
threat to healthcare. Recent years have seen a series of progresses in the early diagnosis …

Renal cell carcinoma (RCC) is one of the most common kidney cancers, responsible for
nearly 90% of all renal malignancies. Despite the availability of many treatment strategies …

The kidney is a vital organ responsible for maintaining homeostasis in the human body.
However, renal cell carcinoma (RCC) is a common malignancy of the urinary system and …

Nanotherapy has emerged as an improved anticancer therapeutic strategy to circumvent the
harmful side effects of chemotherapy. It has been proven to be beneficial to offer multiple …

Background Niosomes are versatile nanocarriers for therapeutic compounds, and optimizing
their structures via ionic surfactants can enhance their functionality considerably. Catanionic …

Renal cell carcinoma (RCC) is a common form of urologic tumor that originates from the
highly heterogeneous epithelium of renal tubules. Over the last decade, targeting therapies …

Renal cell carcinoma (RCC) is one of the most common tumors of the urinary system,
seriously impacting public health. CircRNAs have been indicated as potentially critical …